Insider · CIK 0001271123
David P Luci
Files at ACXP (Acurx Pharmaceuticals, Inc.). First filing Jan 8, 2025, latest Jan 8, 2025.
In brief
David P Luci files SEC Form 4 as CEO, president, director and 10% owner at ACXP (Acurx Pharmaceuticals, Inc.). Since Jan 8, 2025, David P Luci has reported 1 open-market buy worth $50k and 0 open-market sells worth $0, the latest filed on Jan 8, 2025.
A track record needs three past buys with six months of prices behind them; David P Luci has 0, so none is measured yet.
The newest scored trade: bought $50k of ACXP on Jan 6, 2025, filed Jan 8, 2025, scored 47 (moderate).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ACXP: Acurx Pharmaceuticals, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 47Moderate | Acurx Pharmaceuticals, Inc. | $50k 49,261 shares | +5% | - |
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 20, 2026 | ACXP Acurx Pharmaceuticals, Inc. | AGrant or award Stock Optionderivative | +37,100 | $0.00 | $0 | 37,100 | Apr 22, 2026 |
| Feb 5, 2025 | ACXP Acurx Pharmaceuticals, Inc. | AGrant or award Stock Optionderivative | +250,000 | $0.00 | $0 | 250,000 | Feb 6, 2025 |
| Jan 6, 2025 | ACXP Acurx Pharmaceuticals, Inc. | POpen-market purchase Common Stock | +49,261 | $1.02 | $50k | 1,097,458 | Jan 8, 2025 |
| Jan 6, 2025 | ACXP Acurx Pharmaceuticals, Inc. | POpen-market purchase Warrants for Common Stockderivative | +49,261 | $0.00 | $0 | 49,261 | Jan 8, 2025 |
Questions about David P Luci
Answered from the filings on this page, as of the latest one.
Is David P Luci buying or selling?
Not in the last 12 months. David P Luci's latest open-market trade on SEC Form 4 was bought $50k of ACXP on Jan 6, 2025.
How did David P Luci's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and David P Luci has 0.
Where does David P Luci file Form 4?
David P Luci has filed Form 4 at ACXP (Acurx Pharmaceuticals, Inc.) as President and CEO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.